Raltitrexed: all 35 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRCNot yet recruitingNCT06652412Phase 2
- Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled TrialRecruitingNCT05766605Phase 3
- Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled TrialRecruitingNCT05701436Phase 3
- Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer PatientsNot yet recruitingNCT05426811Phase 1/2
- SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal CancerRecruitingNCT05160896Phase 2
- Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRCStatus unknownNCT06427005Phase 2
- RALOX as Second Line Treatment for Advanced Malignant Biliary System TumorStatus unknownNCT05148143Phase 2
- Raltitrexed in HIPECCompletedNCT04761185Phase 1
- Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal CancerStatus unknownNCT04582981Phase 2
- The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic CancerStatus unknownNCT04581876Phase 2
- A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal CancerStatus unknownNCT04241731Phase 2
- RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)Status unknownNCT03813641Phase 2
- Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of EsophagusStatus unknownNCT03585530Phase 2
- Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical ResectionStatus unknownNCT03392103Phase 2
- Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.Status unknownNCT03196843Phase 4
- Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
- Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer PatientsStatus unknownNCT03053167Phase 2
- Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit ElderlyCompletedNCT02992886Phase 2
- Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal CancerStatus unknownNCT02618356Phase 2
- Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-CisplatinCompletedNCT02562599Phase 2
- Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver MetastasesStatus unknownNCT02557490Phase 4
- Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell CancerStatus unknownNCT02485548Phase 3
- Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer PatientsStatus unknownNCT02376452Phase 2
- Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver MetastasesStatus unknownNCT01959061Phase 4
- A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric CancerStatus unknownNCT01836120Phase 2
- A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal CancerStatus unknownNCT01732380Phase 2
- Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy FailureCompletedNCT01348412Phase 2
- A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal CancerCompletedNCT00590278Phase 2
- A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
- Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the PleuraCompletedNCT00004920Phase 3
- Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically RemovedCompletedNCT00004254Phase 2
- Raltitrexed in Treating Children With Refractory Acute LeukemiaCompletedNCT00003528Phase 1
- Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid TumorsCompletedNCT00003109Phase 1
- Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00002828Phase 1
- A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic DiseaseCompletedNCT00001341Phase 1